compound 4b [Ramsey et al., 2023]   Click here for help

GtoPdb Ligand ID: 13022

Compound class: Synthetic organic
Comment: This compound is reported as a selective, allosteric inhibitor of SARS-CoV-2 nsp13 helicase activity [1]. It covalently modifies Cys556 of nsp13, which is distal from its ATP- or RNA-binding sites. Compound 4b has little inhibitory activity on the unwinding function of the human RecQ helicases BLM RecQ like helicase (BLM) and WRN RecQ like helicase (WRN).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 4
Topological polar surface area 29.54
Molecular weight 329.82
XLogP 2.63
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H]1CCC2=C(C=CC(=C2)C3=CC=C(C=C3)OC)N1C(=O)CCl
Isomeric SMILES COC1=CC=C(C=C1)C2=CC3=C(C=C2)N([C@@H](C)CC3)C(=O)CCl
InChI InChI=1S/C19H20ClNO2/c1-13-3-4-16-11-15(14-5-8-17(23-2)9-6-14)7-10-18(16)21(13)19(22)12-20/h5-11,13H,3-4,12H2,1-2H3/t13-/m0/s1
InChI Key MEZNCQILQOWEHU-ZDUSSCGKSA-N
References
1. Ramsey JR, Shelton PMM, Heiss TK, Olinares PDB, Vostal LE, Soileau H, Warrington S, Adaniya S, Miller M, Sun S et al.. (2023)
Using a function-first 'scout fragment'-based approach to develop allosteric covalent inhibitors of conformationally dynamic helicase mechanoenzymes.
bioRxiv, Preprint. DOI: 10.1101/2023.09.25.559391 [PMID:37808863]